BERLIN and SEATTLE, March 5, 2007 (PRIME NEWSWIRE) (PRIMEZONE) -- At its meeting on March 1st, the Supervisory Board of Epigenomics AG (Frankfurt:ECX) decided to propose Heino von Prondzynski for election to the Supervisory Board at the next Annual General Meeting of shareholders. Heino von Prondzynski, former CEO of Roche Diagnostics, will replace Bruce L.A. Carter, PhD, CEO of Zymogenetics and member of the Supervisory Board of Epigenomics.
